Hoffman-la Roche Herceptin Product Recall (2020-06-27)

Herceptin Recall Summary Hoffman-La Roche is recalling Herceptin, a cancer treatment drug, across Canada due to product safety concerns. This is a Class I recall, indicating a serious safety issue. The recall affects Herceptin distributed throughout Canada.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2020-06-27
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/763a31e6-ec99-49f1-9a89-839b9f241c1f